Skip to main content

Table 2 Functional and anatomical results in the whole series and in the 2 subgroups

From: Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation

   Baseline
(mean ± SD)
Post-Tx
(mean ± SD)
P = a
Whole Series BCVA (logMAR) 1.23 ± 0.56 0.87 ± 0.41 0.014
(n = 19) CRT (μm) 404.0 ± 131.7 306.1 ± 112.0 0.0002
Subgroups    
Naïve Group BCVA (logMAR) 1.32 ± 0.58 0.92 ± 0.47 0.047
(n = 11) CRT (μm) 436.6 ± 96.6 298.6 ± 87.3 0.003
Pretreatment Group BCVA (logMAR) 1.09 ± 0.54 0.78 ± 0.33 0.173
(n = 8) CRT (μm) 359.1 ± 165.2 316.5 ± 145.4 0.018
  1. BCVA best-corrected visual acuity, CRT central retinal thickness, LogMAR logarithm of the minimum angle of resolution, Post-Tx post-treatment, SD Standard deviation
  2. aWilcoxon Signed Ranks Test (2-tailed)